{"cdcTestId":"2013-0819","testcaseName":"# 1 MMRV at 12 m-4 days","vaccineGroup":"VAR","evaluationTestType":"Age: At Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2021-10-23T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PROQUAD","cvx":"94","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2023-01-23T00:00:00","recommendedDate":"2025-10-23T00:00:00","pastDueDate":"2028-11-19T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PROQUAD","cvx":"94","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-02T08:38:18.717","generalDescription":"This test case describes when the first dose of varicella vaccine (ProQuad) is administered at 12 months - 4 days of age, that it is considered to be valid, and a second dose should be forecasted.","changedInVersion":"1.0","reasonForChange":""}